Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 5, 2002, Pages 517-525

  Kranenburg, Andor R ^a   De Boer, Willem I ^a   Van Krieken, J Han J M ^a   Mooi, Wolter J ^a   Walters, Jane E ^a   Saxena, Pramod R ^a   Sterk, Peter J ^a   Sharma, Hari S ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036846226     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.4474     Document Type: Article

References (34)

1. Barnes, P. J. 1998. Chronic obstructive pulmonary disease: New opportunities for drug development. Trends Pharmacol. Sci. 19:415-423.
2. Madison, J. M., and R. S. Irwin. 1998. Chronic obstructive pulmonary disease. Lancet 352:467-473.
3. Barnes, P. J. 1998. Pharmacology of airway smooth muscle. Am. J. Respir. Crit. Care Med. 158:S123-132.
4. Wright, J. L., L. Lawson, P. D. Pare, R. O. Hooper, D. I. Peretz, J. M. Nelems, M. Schulzer, and J. C. Hogg. 1983. The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise. Am. Rev. Respir. Dis. 128:702-707.
5. Magee, F., J. L. Wright, B. R. Wiggs, P. D. Pare, and J. C. Hogg. 1988. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax 43:183-189.
6. Jeffery, P. K. 1998. Structural and inflammatory changes in COPD: A comparison with asthma. Thorax 53:129-136.
7. Holgate, S. T. 1997. Asthma: A dynamic disease of inflammation and repair. Ciba Found. Symp. 206:5-34.
8. Werner, S. 1998. Keratinocyte growth factor: A unique player in epithelial repair processes. Cytokine Growth Factor Rev. 9:153-165.
9. Szebenyi, G., and J. F. Fallon. 1999. Fibroblast growth factors as multifunctional signaling factors. Int. Rev. Cytol. 185:45-106.
10. Barrios, R., A. Pardo, C. Ramos, M. Montano, R. Ramirez, and M. Selman. 1997. Upregulation of acidic fibroblast growth factor during development of experimental lung fibrosis. Am. J. Physiol. 273:L451-458.
11. al-Dossari, G. A., J. Jessurun, R. M. Bolman iii, V. R. Kshettry, M. B. King, J. J. Murray, and M. I. Hertz. 1995. Pathogenesis of obliterative bronchiolitis: Possible roles of platelet-derived growth factor and basic fibroblast growth factor. Transplantation 59:143-145.
12. Singh, T. M., K. Y. Abe, T. Sasaki, Y. J. Zhuang, H. Masuda, and C. K. Zarins. 1998. Basic fibroblast growth factor expression precedes flow-induced arterial enlargement. J. Surg. Res. 77:165-173.
13. Bryant, S. R., R. J. Bjercke, D. A. Erichsen, A. Rege, and V. Lindner. 1999. Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2. Circ. Res. 84:323-328.
14. Grashoff, W. F., J. K. Sont, P. J. Sterk, P. S. Hiemstra, W. I. de Boer, J. Stolk, J. Han, and J. M. van Krieken. 1997. Chronic obstructive pulmonary disease: Role of bronchiolar mast cells and macrophages. Am. J. Pathol. 151:1785-1790.
15. de Boer, W. I., A. van Schadewijk, J. K. Sont, H. S. Sharma, J. Stolk, P. S. Hiemstra, and J. H. van Krieken. 1998. Transforming growth factor β 1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 158:1951-1957.
16. Quanjer, P. H., G. J. Tammeling, J. E. Cotes, O. F. Pedersen, R. Peslin, and J. C. Yernault. 1993. Lung volumes and forced ventilatory flows: Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European Respiratory Society. Eur. Respir. J. Suppl. 16:5-40.
17. Coope, R. C., P. J. Browne, C. Yiangou, G. S. Bansal, J. Walters, N. Groome, S. Shousha, C. L. Johnston, R. C. Coombes, and J. J. Gomm. 1997. The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue. Br. J. Cancer 75:1621-1630.
18. Yiangou, C., H. Cox, G. S. Bansal, R. Coope, J. J. Gomm, R. Barnard, J. Walters, N. Groome, S. Shousha, R. C. Coombes, and C. L. Johnston. 1997. Down-regulation of a novel form of fibroblast growth factor receptor 1 in human breast cancer. Br. J. Cancer 76:1419-1427.
19. Wright, J. L., T. Petty, and W. M. Thurlbeck. 1992. Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial. Lung 170:109-124.
20. Peinado, V. I., J. A. Barbera, J. Ramirez, F. P. Gomez, J. Roca, L. Jover, J. M. Gimferrer, and R. Rodriguez-Roisin. 1998. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am. J. Physiol. 274:L908-913.
21. Peinado, V. I., J. A. Barbera, P. Abate, J. Ramirez, J. Roca, S. Santos, and R. Rodriguez-Roisin. 1999. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 159:1605-1611.
22. Barbera, J. A., A. Riverola, J. Roca, J. Ramirez, P. D. Wagner, D. Ros, B. R. Wiggs, and R. Rodriguez-Roisin. 1994. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 149:423-429.
23. Wright, J. L., L. M. Lawson, P. D. Pare, B. J. Wiggs, S. Kennedy, and J. C. Hogg. 1983. Morphology of peripheral airways in current smokers and ex-smokers. Am. Rev. Respir. Dis. 127:474-477.
24. Jones, R., M. Jacobson, and W. Steudel. 1999. α-smooth-muscle actin and microvascular precursor smooth-muscle cells in pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 20:582-594.
25. Hughes, S. E., and P. A. Hall. 1993. Immunolocalization of fibroblast growth factor receptor 1 and its ligands in human tissues. Lab. Invest. 69:173-182.
26. Liebler, J. M., M. A. Picou, Z. Qu, M. R. Powers, and J. T. Rosenbaum. 1997. Altered immunohistochemical localization of basic fibroblast growth factor after bleomycin-induced lung injury. Growth Factors 14:25-38.
27. Scheinowitz, M., D. Abramov, and M. Eldar. 1997. The role of insulin-like and basic fibroblast growth factors on ischemic and infarcted myocardium: A mini review. Int. J. Cardiol. 59:1-5.
28. Becerril, C., A. Pardo, M. Montano, C. Ramos, R. Ramirez, and M. Selman, 1999. Acidic fibroblast growth factor induces an antifibrogenic phenotype in human lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 20:1020-1027.
29. Pickering, J. G., C. M. Ford, B. Tang, and L. H. Chow. 1997. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells: Evidence for repressed collagen production and activated degradative capacity. Arterioscler. Thromb. Vasc. Biol. 17:475-482.
30. Stachowiak, M. K., P. A. Maher, A. Joy, E. Mordechai, and E. K. Stachowiak. 1996. Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. Brain Res. Mol. Brain Res. 38:161-165.
31. Jones, R., W. Steudel, S. White, M. Jacobson, and R. Low. 1999. Microvessel precursor smooth muscle cells express head-inserted smooth muscle myosin heavy chain (SM-B) isoform in hyperoxic pulmonary hypertension. Cell Tissue Res. 295:453-465.
32. Chen, C. H., and P. D. Henry. 1997. Atherosclerosis as a microvascular disease: Impaired angiogenesis mediated by suppressed basic fibroblast growth factor expression. Proc. Assoc. Am. Physicians 109:351-361.
33. Ambalavanan, N., A. Bulger, and I. J. Philips. 1999. Hypoxia-induced release of peptide growth factors from neonatal porcine pulmonary artery smooth muscle cells. Biol. Neonate 76:311-319.
34. Saetta, M., A. Di Stefano, G. Turato, F. M. Facchini, L. Corbino, C. E. Mapp, P. Maestrelli, A. Ciaccia, and L. M. Fabbri. 1998. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157:822-826.